EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Pilot study on anti‐reflux mucoplasty: Advancing endoscopic anti‐reflux therapy for gastroesophageal reflux disease

Haruhiro Inoue, Kazuki Yamamoto iD, Yuto Shimamura iD, Daisuke Azuma, Kei Ushikubo, Hiroki Okada, Yoshiaki Kimoto iD, Yohei Nishikawa, Ippei Tanaka iD, Mayo Tanabe iD, Manabu Onimaru, Marc Julius Navarro

Digestive Endoscopy · 2024

DOI: 10.1111/den.14711 ↗

At a glance

Journal article in Digestive Endoscopy, 2024. Written by Haruhiro Inoue and 11 co-authors. Institution: Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan. Major MEDLINE topics: Gastroesophageal Reflux. Cited 31 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objectives

Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) were developed as interventions for proton pump inhibitor (PPI)‐refractory/‐dependent gastroesophageal reflux disease (GERD). Although ARMS and ARMA are established treatments for PPI‐refractory GERD, reliance on natural healing for ulcer scar formation introduces uncertainty and bleeding risk. To address these issues, we introduced a novel approach called anti‐reflux mucoplasty (ARM‐P), which involves immediate closure of mucosal defects following mucosectomy. This pilot study aims to evaluate the safety, feasibility, and efficacy of ARM‐P.

Methods

A retrospective single‐center study was conducted using prospectively collected data from October 2022 to July 2023. Patients with PPI‐refractory/‐dependent GERD who underwent ARM‐P were included. The study evaluated technical success of ARM‐P, before and after ARM‐P GERD‐Health Related Quality of Life Questionnaire, GerdQ, and Frequency Scale for the Symptoms of GERD scores, along with PPI discontinuation and endoscopic esophagogastric junction morphology.

Results

A total of 20 patients with a median age of 61.5 years underwent the ARM‐P procedure. The procedure achieved 100% technical success without adverse events. After ARM‐P, 55.0% discontinued PPI usage and 15.0% reduced PPI dose by half. Median GERD‐Health Related Quality of Life Questionnaire score improved from 21 to 6 ( P = 0.0026), median GerdQ score improved from 9 to 7 ( P = 0.0022), and median Frequency Scale for the Symptoms of GERD score decreased from 16 to 7 ( P = 0.0003). Median Hill's Classification significantly improved from grade III to grade I ( P = 0.0001).

Conclusions

This study presents the first pilot report of ARM‐P, demonstrating its procedural safety, technical feasibility, and short‐term efficacy.

Subjects

MeSH terms (MEDLINE)

Gastroesophageal RefluxHumansPilot ProjectsMiddle AgedMaleFemaleRetrospective StudiesAgedTreatment OutcomeFeasibility StudiesEndoscopic Mucosal ResectionProton Pump InhibitorsAdultQuality of Life

Author keywords

anti‐reflux mucoplastyanti‐reflux mucosal ablationanti‐reflux mucosectomyendoscopic anti‐reflux therapygastroesophageal reflux disease

Substances

Proton Pump Inhibitors

Authors and institutions

  • Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
  • Institute of Digestive and Liver Diseases, St. Luke's Medical Center, Quezon City, Philippines.

ORCID profiles: Kazuki Yamamoto, Yuto Shimamura, Yoshiaki Kimoto, Ippei Tanaka, Mayo Tanabe

Cite

APA

Inoue, H., Yamamoto, K., Shimamura, Y., Azuma, D., Ushikubo, K., Okada, H., Kimoto, Y., Nishikawa, Y., Tanaka, I., Tanabe, M., Onimaru, M., & Navarro, M. J. (2024). Pilot study on anti‐reflux mucoplasty: Advancing endoscopic anti‐reflux therapy for gastroesophageal reflux disease. Digestive Endoscopy. https://doi.org/10.1111/den.14711

Vancouver

Inoue H, Yamamoto K, Shimamura Y, Azuma D, Ushikubo K, Okada H, et al. Pilot study on anti‐reflux mucoplasty: Advancing endoscopic anti‐reflux therapy for gastroesophageal reflux disease. Digestive Endoscopy. 2024. doi:10.1111/den.14711

BibTeX
@article{Inoue2024,
  author = {Inoue, Haruhiro and Yamamoto, Kazuki and Shimamura, Yuto and Azuma, Daisuke and Ushikubo, Kei and Okada, Hiroki and Kimoto, Yoshiaki and Nishikawa, Yohei and Tanaka, Ippei and Tanabe, Mayo and Onimaru, Manabu and Navarro, Marc Julius},
  title = {Pilot study on anti‐reflux mucoplasty: Advancing endoscopic anti‐reflux therapy for gastroesophageal reflux disease},
  journal = {Digestive Endoscopy},
  year = {2024},
  doi = {10.1111/den.14711}
}
Start for free →